Department of Epidemiology and public health, Sciensano, Brussels, Belgium.
Agence pour une Vie de Qualité, Charleroi, Belgium.
Vaccine. 2021 Sep 15;39(39):5456-5460. doi: 10.1016/j.vaccine.2021.08.060. Epub 2021 Aug 19.
In Belgium, high-risk contacts of an infected person were offered PCR-testing irrespective of their vaccination status. We estimated vaccine effectiveness (VE) against infection and onwards transmission, controlling for previous infections, household-exposure and temporal trends. We included 301,741 tests from 25 January to 24 June 2021. Full-schedule vaccination was associated with significant protection against infection. In addition, mRNA-vaccines reduced onward transmission: VE-estimates increased to >90% when index and contact were fully vaccinated. The small number of viral-vector vaccines included limited interpretability.
在比利时,无论感染者的疫苗接种状况如何,高风险接触者都可以接受 PCR 检测。我们根据既往感染、家庭暴露和时间趋势控制因素,估计了疫苗对感染及后续传播的有效性(VE)。我们纳入了 2021 年 1 月 25 日至 6 月 24 日的 301741 次检测。全疗程疫苗接种与显著的感染保护相关。此外,mRNA 疫苗降低了后续传播:当指数和接触者都完全接种疫苗时,VE 估计值增加到>90%。纳入的少数病毒载体疫苗数量有限,解释能力有限。